Engaging with active and well-informed individuals is the essential element of any successful health ecosystem. Without them, healthcare and digital health companies are building solutions that can’t improve health outcomes. Patient advocacy groups are one way that individuals can become empowered. But across the world, the impact of such groups is dependent on external factors to help them achieve scale. In this episode, I speak with Ruth Kuguru, the Regional Head for Communications and Patient Engagement for Novartis who has developed a platform to change this dynamic for patient advocacy groups. During this podcast, we discuss: How Novartis created a platform to bring together different stakeholders and putting patients at the forefront of improving Habitats – another word for Ecosystems Describing the components of the Alliance & Partnerships for Patient Innovation & Solutions (APPIS) including a case study in the Philippines Why patient advocacy groups are the “real deal” for creating engaged individuals Scaling the impact of patient advocacy into a corporate capability that goes beyond the traditional model for pharma manufacturers About Ruth Kuguru Ruth Kuguru is the Executive Director, Communications & Patient Engagement for Novartis Asia Pacific, Middle East, and Africa. In her role, she leads her team to foster open, inclusive, and strong partnerships with patient communities, media, and healthcare leaders in Asia Pacific, Middle East and African countries. She is passionate about the impact strong collaboration can have in accelerating access and developing innovative solutions for patients. Guest's Links and Resources Connect with Ruth Kuguru: LinkedIn Novartis: Website Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Akili | Bayer G4A | Lindus Health

In this episode of #DTxPodcast, Eugene Borukhovich sits down with Acacia Parks, Founder of Liquid Amber Consulting. Liquid Amber helps digital health and DTx companies support the claims they want to make using scientific evidence, in the ways that will be compelling to the audiences they care about. Topics include: A Day in the Life of a Chief Science Officer: Gain insights into the role of a Chief Science Officer before Acacia Parks ventured into her own entrepreneurial journey, and get a glimpse into the challenges and responsibilities involved in the position. Liquid Amber: Uncover the story behind the name "Liquid Amber" and explore the mission and vision of the company. Evidence Generation Process: Dive deep into the process of setting up the right processes and PDT vs non PDT. Active Ingredients in DTx: Discover how active ingredients play a crucial role in both molecular-based and software-based interventions. Pro Tips for Regulatory Approvals: Acacia Parks shares her expert advice on getting regulatory approvals for DTx. Learn what companies should do before, during, and right after the regulatory process to streamline the approval journey. Being a Patient on Freespira: Get a firsthand perspective as Acacia Parks walks us through her personal experience using Freespira. Guest Links and Resources: Connect with Acacia Parks on LinkedIn Visit liquidamber.consulting Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Join host Tony Estrella each month as he explores with his guests what it takes to build successful ecosystems across Asia-Pacific. You’ll hear thought-provoking interviews with industry leaders, entrepreneurs, and investors who bring real-life examples of building effective partnerships that solve some of the most important healthcare challenges across this vibrant region. Whether you’re already in healthcare, a tech enthusiast, or simply curious about what is happening in Asia-Pacific, tune in to the APAC Edition of Digital Health Today. Host's Links and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony’s Book: Comatose FutureProofing Healthcare | FutureProofing Healthcare APAC index Full White Paper, Summary and Video: A Vision for Asia Pacific in 2050 Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Special thanks to: Amalgam Rx | Akili | Bayer G4A | Lindus Health

In this episode Eugene Borukhovich sits down with Ameya Phadke, Ph.D., Patient Non-Pharma Solutions Leader at Chiesi Group. Join them as they delve into the world of digital therapeutics and explore how pharma companies are embracing digital health to revolutionize patient care. Topics include: The Chiesi Group's History: Discover the largest international pharmaceutical Group certified as a B Corp, with a rich history spanning over 80 years, and their focus on respiratory diseases, special care, and rare diseases. Pharma Moving into the Digital Health Space: Gain insights into how Chiesi Group recognized the need to go beyond medications to deliver impactful outcomes for patients, leading them to explore the digital therapeutics field. The Kaia Deal: Learn about Chiesi's partnership with Kaia and their shared vision to address the access gap in pulmonary rehabilitation through digital solutions, exemplifying the power of collaboration and building something impactful together. Standalone Digital Therapeutics vs. Disease Management: Understand the importance of both standalone digital therapeutics and disease management platforms in the patient journey, with each serving unique purposes and addressing different aspects of care. Chiesi's Partnership with Aptar: Explore Chiesi's collaboration with Aptar, aiming to make disease management practices more accessible to patients by bringing services to their fingertips, ultimately empowering patients and enhancing respiratory care. Challenges of Drug+: Reflect on the challenges and opportunities that arise when combining digital therapeutics with pharma, including the need to align the mechanism of action with desired outcomes and the importance of identifying viable use cases. The Future of DTx after Pear Therapeutics: Gain insights into the evolving digital therapeutics landscape and the enduring mission of Chiesi Group and other companies to leverage digital solutions to improve patient lives, regardless of market trends. Guest Links and Resources: Connect with Ameya Phadke on LinkedIn Visit www.chiesi.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we hear from Jens Noertershaeuser, Founder & Co-CEO of Kranus Health. In their own words, Kranus Health’s mission is to revolutionize men's health by providing innovative and accessible healthcare solutions. As one of only 10 companies with a permanent approval, Kranus Edera is the only the first digital health app (DiGA) for the treatment of erectile dysfunction. In this episode, we cover: The background to Kranus Health The focus on men’s health and erectile dysfunction as a flagship product Products in development and the future of Kranus Health The funding journey Patient experience using the product Evidence generation and the DiGA process Insurance company reimbursment Guest Links and Resources: Connect with Jens Noertershaeuser on LinkedIn Visit kranushealth.com Host Links: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App HealthXL: Website | Twitter | Join an Event Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to: > Presenting Partner: Amalgam Rx > Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health Follow Digital Health Today: Browse Episodes | Twitter | LinkedIn | Facebook | Instagram Follow Health Podcast Network: Browse Shows | LinkedIn | Twitter | Facebook | Instagram